Clinical Trial Update: Nivolumab in Combination With Temozolomide and Radiotherapy in Children and Adolescents With Newly Diagnosed High-grade Glioma [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/2 trial evaluating nivolumab in combination with temozolomide and radiotherapy for newly diagnosed pediatric high-grade glioma; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma

Drugs mentioned

• Temozolomide (Temozolomide)
• nivolumab (nivolumab)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: High Grade Glioma | Phase 1, Phase 2 | Status: COMPLETED